FDA Scrutiny of Promotion and Advertising - 2017

DTC may be deemed as misbranding your product and, therefore, may not be marketed. Firms must be more sophisticated now in designing their advertising methods and messages. The days of looking at text alone for a magazine insert are long gone. You should pay attention to the components of your advertising in mass media, such as volume; images; information prominence and conspicuousness; speed of the message subliminal messaging and "the take away message." This means you need to understand what each component of the advertising attempts to accomplish and then evaluate the integrated message, i.e., the "take away." The difficulty is that this broad horizon of factors gives the FDA abundant opportunities to say that you have misbranded your product. Hence, it is illegal.

Why should you Attend:

That is expensive and leaves you with a cloud over your name at the FDA. That is never a good thing. You must know what you are doing with DTC advertising, not just hope you do. You will probably earn a Warning Letter by "Winging it."

Areas Covered in the Session:

• FDA's approach to DTC advertising and promotion principles
• FDA guidance and use of cognitive psychology
• Types of violation for illegal DTC advertising practices
• The role of sales and marketing departments

Who Will Benefit:

• Own Label Distributors
• International Trade Managers
• Product Specification Developer